Skip to content

Author

Zhihui Wang

We have 2 of 5 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Integrating ferroptosis and the tumor-immune gene mutations interface: a novel lenvatinib resistance prognostic signature with YWHAB-related immunotherapeutic correlates in hepatocellular carcinoma.

Targeting YWHAB may represent a promising therapeutic strategy to overcome lenvatinib resistance in HCC, and the FLRPS serves as an effective predictive model for the prognosis of HCC.

Hang Yu, Zhi-Hui Wang, Hong-Liang Zou et al. · 0 citations
Open access Jul 2026

TRIM27-Cas9-loaded EVs suppress HCC proliferation and enhance responsiveness to anti-PD-1 therapy by promoting ACSL4-mediated ferroptosis.

It is suggested that TRIM27 confers ferroptosis resistance via facilitating K48-linked ubiquitination and subsequent proteasomal degradation of ACSL4 and developed TRIM27-Cas9-loaded EVs with robust editing efficiency.

Jie Wen, Zhihui Wang, Zhirui Zeng et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.